Table 2.

Rates of responders to treatment and utilities at baseline, and 3- and 6-month follow-ups by group (N=329) for the complaint-directed mini-intervention (CDMI) and control groups.

Measure	CDMI group (n=165)				Control group (n=164)
	Baseline	3 months	6 months	Baseline		3 months	6 months
Rates of responders to treatment based on IDS-SRa, n (%)	N/Ab	23 (13.9)	31 (18.8)	N/A		12 (7.3)	19 (11.6)
Utilities and quality-adjusted life-yearsc gained, mean (SD)	N/A	0.15 (0.02)	0.15 (0.02)	N/A		0.03 (0.02)	0.16 (0.01)

^aIDS-SR: Inventory of Depressive Symptomatology Self-Report.

^bN/A: not applicable.

^cCalculated using a translation factor to transform differences in effect size to changes in utility for people with depression developed by Sanderson et al [23].